Zydus Wellness logo

Zydus Wellness CEO, MD, chairman, board of directors and AGM

NSE: ZYDUSWELLBSE: 531335Food ProductsSmall Cap

Last close ₹463.35down ₹11.95 (2.51%)BSE ₹460.90

Share price at the NSE close on 23 Oct 2026. Previous close ₹475.30.

52-week range of traded prices to 23 Oct 2026
₹367.55Low, 2 Mar 2026₹611.85High, 20 Jul 2026
Market cap
₹14,742 Cr434th largest listed
P/E
78.3
P/E without one-offs
64.4
P/B
2.5
Dividend yield
0.26%
ROE
3.3%
ROE without one-offs
4.0%
ROCE
4.5%
Debt to equity
0.55
Volume, NSE
1,44,93646.0% delivered

Zydus Wellness board of directors

At the end of the quarter to Sep 2026, as the company filed it; changes since are in its announcements.Their trades in its shares

  • ChairpersonSHARVIL PANKAJBHAI PATELRelated to the promoter
  • Chief executiveTARUN ARORA
  • Company Secretary and Compliance OfficerNandish P. Joshi

8 directors5 independent1 executive2 non-executive

  • SHARVIL PANKAJBHAI PATEL · ChairpersonNon-executive · joined Apr 2009 · reappointed Aug 2026 · 3 listed boards · 1 as independent · 3 committee seats, 1 as chair
  • DHARMISHTA NARENDRAPRASAD RAWALIndependent · joined Mar 2019 · reappointed Mar 2024 · 90 months as independent · 1 listed board · 1 as independent · 5 committee seats, 1 as chair
  • SRI VISHNU RAJU NANDYALAIndependent · joined Mar 2019 · reappointed Mar 2024 · 90 months as independent · 1 listed board · 1 as independent · 2 committee seats
  • AKHIL MONAPPAIndependent · joined May 2023 · reappointed May 2023 · 40 months as independent · 2 listed boards · 2 as independent · 2 committee seats, 1 as chair
  • KULIN SANJAY LALBHAIIndependent · joined Nov 2016 · reappointed Jul 2021 · 118 months as independent · 6 listed boards · 2 as independent · 4 committee seats, 2 as chair
  • GANESH NARAYAN NAYAKNon-executive · joined Jul 2006 · reappointed Jul 2025 · 2 listed boards · 2 committee seats, 1 as chair
  • TARUN ARORA · Chief executiveExecutive · joined May 2015 · reappointed May 2025 · 1 listed board · 1 committee seat
  • APURVA SHISHIR DIWANJIIndependent · joined May 2026 · reappointed May 2026 · 4 months as independent · 2 listed boards · 2 as independent · 4 committee seats

An independent director has no business or family tie to the company, its promoters or its managers beyond the seat. Listed boards counts the boards of listed companies the director sits on, this one included, and "as independent" how many of those seats are independent ones. Committee seats are audit and stakeholder committee seats across those companies. Months as independent is filed for independent directors only, whose terms the rules cap. Disqualified is the company's own mark that a director may not serve under company law.

Committees and meetings

Who sits on each, and how often they met.Board meeting notices and outcomes

  • Board

    • 4 Aug 20267 of 8 present4 independent · 77 days in between
    • 18 May 20268 of 8 present5 independent
  • Audit Committee

    Chair DHARMISHTA NARENDRAPRASAD RAWAL

    SRI VISHNU RAJU NANDYALA, KULIN SANJAY LALBHAI, GANESH NARAYAN NAYAK, AKHIL MONAPPA

    • 4 Aug 20264 of 5 present3 independent · 77 days in between
    • 18 May 20265 of 5 present4 independent
  • Nomination and remuneration committee

    Chair KULIN SANJAY LALBHAI

    DHARMISHTA NARENDRAPRASAD RAWAL, SRI VISHNU RAJU NANDYALA

    • 18 May 20263 of 3 present3 independent
  • Stakeholders Relationship Committee

    Chair GANESH NARAYAN NAYAK

    SRI VISHNU RAJU NANDYALA, TARUN ARORA

    • 18 May 20263 of 3 present1 independent
  • Risk Management Committee

    Chair SHARVIL PANKAJBHAI PATEL

    AKHIL MONAPPA, KULIN SANJAY LALBHAI, UMESH VINODRAY PARIKH

    • 5 May 20263 of 4 present1 independent
  • Corporate Social Responsibility Committee

    Chair SHARVIL PANKAJBHAI PATEL

    KULIN SANJAY LALBHAI, GANESH NARAYAN NAYAK

    • 18 May 20263 of 3 present1 independent
  • Share Transfer Committee

    Chair SHARVIL PANKAJBHAI PATEL

    GANESH NARAYAN NAYAK, TARUN ARORA

    No meeting listed in the filing.

  • Finance and Administration Committee

    Chair SHARVIL PANKAJBHAI PATEL

    GANESH NARAYAN NAYAK, TARUN ARORA

    No meeting listed in the filing.

Meetings in the quarter filed and the one before it. The days in between are as the company files them, neither meeting's day counted; the rules allow at most 120. A quorum is the least number of members who must attend for the meeting to decide anything.

Statutory auditor

Named in the results for the quarter to Mar 2026.

  • M/s. Mukesh M. Shah & Co.Peer-review certificate valid to Jan 2027

A statutory auditor checks the company's accounts and signs its results. Peer review is the accountants' institute's check of an audit firm's own work, which a listed company's auditor must hold a valid certificate of.

Zydus Wellness AGM and shareholder votes

Each resolution, how the votes went, and how institutions voted apart from the promoters. A postal ballot is a vote by post or online, held without a meeting.Zydus Wellness dividend history

Annual general meeting, 4 Aug 2026

90,662 shareholders on the register on 28 Jul 2026; present: 10 promoters and 51 others; votes counted by Hitesh Buch / Hitesh Buch & Associates.The company's voting result (opens in a new tab)

  1. Adoption of Standalone Audited Financial Statements for the financial year ended on March 31, 2026 and the Report of Board of Directors and Auditors thereon
    Ordinary
    100.00% for0.00% against

    Against: promoters 0.00% · institutions 0.00% · other public 0.99%

    Turnout: all 91.26% · promoters 99.97% · institutions 95.27% · other public 0.24%

  2. Adoption of Consolidated Audited Financial Statements for the financial year ended on March 31, 2026 and the Report of Auditors thereon
    Ordinary
    100.00% for0.00% against

    Against: promoters 0.00% · institutions 0.00% · other public 0.99%

    Turnout: all 91.26% · promoters 99.97% · institutions 95.27% · other public 0.24%

  3. Declaration of Dividend of Rs. 1.20 per equity share of Rs. 2/- each for the financial year ended on March 31, 2026
    Ordinary
    100.00% for0.00% against

    Against: promoters 0.00% · institutions 0.00% · other public 1.05%

    Turnout: all 91.27% · promoters 99.97% · institutions 95.31% · other public 0.24%

  4. Re-appointment of Dr. Sharvil P. Patel, as a Non-Executive Director of the Company, liable to retire by rotation
    OrdinaryPromoters have an interest in it
    97.42% for2.58% against

    Against: promoters 0.00% · institutions 10.88% · other public 3.82%

    Turnout: all 91.26% · promoters 99.96% · institutions 95.31% · other public 0.24%

  5. Appointment of Mr. Apurva S. Diwanji (DIN: 00032072) as an Independent Director of the Company for the term of 5 (five) years
    Special
    87.48% for12.52% against

    Against: promoters 0.00% · institutions 53.20% · other public 15.27%

    Turnout: all 91.06% · promoters 99.97% · institutions 94.39% · other public 0.24%

  6. Ratification of remuneration of R. Nanabhoy & Co., Cost Auditors for the Financial Year ending on March 31, 2027
    Ordinary
    100.00% for0.00% against

    Against: promoters 0.00% · institutions 0.00% · other public 3.71%

    Turnout: all 91.27% · promoters 99.97% · institutions 95.31% · other public 0.24%

For and against are per cent of the votes cast. Turnout is the votes cast as a per cent of the shares each group holds. Institutions are funds, insurers, banks and foreign investors. An ordinary resolution passes with more than half the votes cast, a special one with at least three quarters.

Annual general meeting, 30 Jul 2025, 9 resolutions

68,597 shareholders on the register on 23 Jul 2025; present: 11 promoters and 48 others; votes counted by Hitesh Buch / Hitesh Buch & Associates.The company's voting result (opens in a new tab)

  1. Adoption of Standalone Audited Financial Statements for the financial year ended on March 31, 2025 and the Report of Board of Directors and Auditors thereon
    Ordinary
    100.00% for0.00% against

    Against: promoters 0.00% · institutions 0.00% · other public 0.01%

    Turnout: all 91.53% · promoters 99.98% · institutions 92.48% · other public 14.46%

  2. Adoption of Consolidated Audited Financial Statements for the financial year ended on March 31, 2025 and the Report of Auditors thereon
    Ordinary
    100.00% for0.00% against

    Against: promoters 0.00% · institutions 0.00% · other public 0.01%

    Turnout: all 91.53% · promoters 99.98% · institutions 92.48% · other public 14.46%

  3. Declaration of Dividend of Rs. 6/- per equity share of Rs. 10/- each for the financial year ended on March 31, 2025
    Ordinary
    100.00% for0.00% against

    Against: promoters 0.00% · institutions 0.00% · other public 0.01%

    Turnout: all 91.54% · promoters 99.98% · institutions 92.55% · other public 14.46%

  4. Re-appointment of Mr. Ganesh Nayak, as a Non-Executive Director of the Company, liable to retire by rotation
    Ordinary
    99.83% for0.17% against

    Against: promoters 0.00% · institutions 0.74% · other public 0.01%

    Turnout: all 91.54% · promoters 99.98% · institutions 92.52% · other public 14.46%

  5. Re-appointment of Mukesh M. Shah & Co., Chartered Accountants, as Statutory Auditors of the Company for the second term of five consecutive years
    Ordinary
    99.92% for0.08% against

    Against: promoters 0.00% · institutions 0.34% · other public 0.19%

    Turnout: all 91.54% · promoters 99.98% · institutions 92.52% · other public 14.46%

  6. Sub-division of equity share of Rs. 10/- each into 5 (five) equity shares of Rs. 2/- each
    Ordinary
    100.00% for0.00% against

    Against: promoters 0.00% · institutions 0.00% · other public 0.19%

    Turnout: all 91.54% · promoters 99.98% · institutions 92.52% · other public 14.46%

  7. Alteration of Capital Clause of the Memorandum of Association of the Company
    Ordinary
    100.00% for0.00% against

    Against: promoters 0.00% · institutions 0.00% · other public 0.19%

    Turnout: all 91.54% · promoters 99.98% · institutions 92.52% · other public 14.46%

  8. Appointment of Hitesh Buch & Associates, Company Secretaries, as Secretarial Auditors of the Company for a term of five consecutive years
    Ordinary
    100.00% for0.00% against

    Against: promoters 0.00% · institutions 0.00% · other public 0.19%

    Turnout: all 91.54% · promoters 99.98% · institutions 92.52% · other public 14.46%

  9. Ratification of remuneration of Dalwadi & Associates, Cost Auditors for the Financial Year ending on March 31, 2026
    Ordinary
    100.00% for0.00% against

    Against: promoters 0.00% · institutions 0.00% · other public 0.02%

    Turnout: all 91.54% · promoters 99.98% · institutions 92.52% · other public 14.46%

For and against are per cent of the votes cast. Turnout is the votes cast as a per cent of the shares each group holds. Institutions are funds, insurers, banks and foreign investors. An ordinary resolution passes with more than half the votes cast, a special one with at least three quarters.

Annual general meeting, 2 Aug 2024, 8 resolutions

Present: 10 promoters and 43 others.The company's voting result (opens in a new tab)

  1. Adoption of Standalone Audited Financial Statements for the year ended on March 31, 2024 and the Report of Board of Directors and Auditors thereon
    OrdinaryPromoters have an interest in it
    100.00% for0.00% against

    Against: promoters 0.00% · institutions 0.00% · other public 0.00%

    Turnout: all 91.53% · promoters 100.00% · institutions 89.08% · other public 59.09%

  2. Adoption of Consolidated Audited Financial Statements for the year ended on March 31, 2024 and the Report of Auditors thereon
    Ordinary
    100.00% for0.00% against

    Against: promoters 0.00% · institutions 0.00% · other public 0.00%

    Turnout: all 81.40% · promoters 100.00% · institutions 89.08% · other public 0.02%

  3. Declaration of Final Dividend of ₹ 5/- per equity share of ₹ 10/- each for the financial year ended on March 31, 2024
    Ordinary
    100.00% for0.00% against

    Against: promoters 0.00% · institutions 0.00% · other public 0.00%

    Turnout: all 91.54% · promoters 100.00% · institutions 89.14% · other public 59.09%

  4. Re-appointment of Mr. Tarun Arora, as a Chief Executive Officer & Whole Time Director of the Company, liable to retire by rotation
    Ordinary
    99.98% for0.02% against

    Against: promoters 0.00% · institutions 0.15% · other public 0.00%

    Turnout: all 91.54% · promoters 100.00% · institutions 89.14% · other public 59.09%

  5. Re-appointment of Mr. Tarun Arora, as a Chief Executive Officer & Whole Time Director of the Company for a period of 5 years
    Ordinary
    99.87% for0.13% against

    Against: promoters 0.00% · institutions 1.04% · other public 0.00%

    Turnout: all 91.54% · promoters 100.00% · institutions 89.14% · other public 59.09%

  6. Continuation of Mr. Ashish Bhargava as a Nominee Director of the Company
    Ordinary
    99.88% for0.12% against

    Against: promoters 0.00% · institutions 0.85% · other public 1.60%

    Turnout: all 81.42% · promoters 100.00% · institutions 89.14% · other public 0.09%

  7. Approval of Commission payable to the Non-Executive Directors
    Ordinary
    100.00% for0.00% against

    Against: promoters 0.00% · institutions 0.00% · other public 0.00%

    Turnout: all 91.54% · promoters 100.00% · institutions 89.14% · other public 59.09%

  8. Ratification of remuneration of Dalwadi & Associates, Cost Auditors for the Financial Year ending on March 31, 2025
    Ordinary
    100.00% for0.00% against

    Against: promoters 0.00% · institutions 0.00% · other public 0.00%

    Turnout: all 91.54% · promoters 100.00% · institutions 89.14% · other public 59.09%

For and against are per cent of the votes cast. Turnout is the votes cast as a per cent of the shares each group holds. Institutions are funds, insurers, banks and foreign investors. An ordinary resolution passes with more than half the votes cast, a special one with at least three quarters.

Annual general meeting, 3 Aug 2023, 8 resolutions

Present: 20 promoters and 88 others.The company's voting result (opens in a new tab)

  1. Adoption of Standalone Audited Financial Statements for the year ended on March 31, 2023 and the Report of Board of Directors and Auditors thereon.
    Ordinary
    100.00% for0.00% against

    Against: promoters 0.00% · institutions 0.00% · other public 0.00%

    Turnout: all 90.69% · promoters 100.00% · institutions 87.97% · other public 59.90%

  2. Adoption of Consolidated Audited Financial Statements for the year ended on March 31, 2023 and the Report of Auditors thereon.
    Ordinary
    100.00% for0.00% against

    Against: promoters 0.00% · institutions 0.00% · other public 0.00%

    Turnout: all 90.69% · promoters 100.00% · institutions 87.97% · other public 59.90%

  3. Declaration of Final Dividend of ₹ 5/- per equity share of ₹ 10/- each for the financial year ended on March 31, 2023.
    Ordinary
    100.00% for0.00% against

    Against: promoters 0.00% · institutions 0.00% · other public 0.00%

    Turnout: all 90.70% · promoters 100.00% · institutions 88.03% · other public 59.90%

  4. Re-appointment of Dr. Sharvil P. Patel (DIN: 00131995), as a Non-Executive Director of the Company who retires by rotation in the AGM and being eligible, offers himself.
    OrdinaryPromoters have an interest in it
    100.00% for0.00% against

    Against: promoters 0.00% · institutions 0.01% · other public 0.00%

    Turnout: all 90.69% · promoters 99.99% · institutions 88.03% · other public 59.90%

  5. Re-appointment of Ms. Dharmishtaben N. Raval (DIN: 02792246) as an Independent Director of the Company for the second term of 5 (five) consecutive years.
    Special
    94.40% for5.60% against

    Against: promoters 0.00% · institutions 41.68% · other public 0.02%

    Turnout: all 90.70% · promoters 100.00% · institutions 88.03% · other public 59.90%

  6. Re-appointment of Mr. Srivishnu R. Nandyala (DIN: 00025063) as an Independent Director of the Company for the second term of 5 (five) consecutive years.
    Special
    99.94% for0.07% against

    Against: promoters 0.00% · institutions 0.46% · other public 0.02%

    Turnout: all 90.70% · promoters 100.00% · institutions 88.03% · other public 59.90%

  7. Appointment of Mr. Akhil A. Monappa (DIN: 09784366) as an Independent Director of the Company for the first term of 5 (five) consecutive years.
    Special
    100.00% for0.00% against

    Against: promoters 0.00% · institutions 0.00% · other public 0.02%

    Turnout: all 90.70% · promoters 100.00% · institutions 88.03% · other public 59.90%

  8. Ratification of remuneration of Dalwadi & Associates, Cost Auditors for the Financial Year ending on March 31, 2024
    Ordinary
    100.00% for0.00% against

    Against: promoters 0.00% · institutions 0.00% · other public 0.00%

    Turnout: all 90.70% · promoters 100.00% · institutions 88.03% · other public 59.90%

For and against are per cent of the votes cast. Turnout is the votes cast as a per cent of the shares each group holds. Institutions are funds, insurers, banks and foreign investors. An ordinary resolution passes with more than half the votes cast, a special one with at least three quarters.

Annual general meeting, 29 Jul 2022, 5 resolutions

Present: 9 promoters and 49 others.The company's voting result (opens in a new tab)

  1. Adoption of Standalone Audited Financial Statements for the year ended on March 31, 2022 and the Report of Board of Directors and Auditors thereon
    Ordinary
    100.00% for0.00% against

    Against: promoters 0.00% · institutions 0.00% · other public 0.00%

    Turnout: all 90.70% · promoters 100.00% · institutions 81.04% · other public 66.56%

  2. Adoption of Consolidated Audited Financial Statements for the year ended on March 31, 2022 and the Report of Auditors thereon
    Ordinary
    100.00% for0.00% against

    Against: promoters 0.00% · institutions 0.00% · other public 0.00%

    Turnout: all 90.70% · promoters 100.00% · institutions 81.04% · other public 66.56%

  3. Declaration of Final Dividend of Rs. 5/- per equity share of Rs. 10/- each for the financial year ended on March 31, 2022
    Ordinary
    100.00% for0.00% against

    Against: promoters 0.00% · institutions 0.00% · other public 0.00%

    Turnout: all 90.70% · promoters 100.00% · institutions 81.07% · other public 66.56%

  4. Re-appointment of Mr. Ganesh N. Nayak (DIN: 00017481), as a Non-Executive Director of the Company who retires by rotation in the AGM and being eligible, offers himself for re-appointment.
    Ordinary
    99.89% for0.11% against

    Against: promoters 0.00% · institutions 0.73% · other public 0.00%

    Turnout: all 90.70% · promoters 100.00% · institutions 81.07% · other public 66.56%

  5. Ratification of remuneration to Cost Auditors
    Ordinary
    100.00% for0.00% against

    Against: promoters 0.00% · institutions 0.00% · other public 0.01%

    Turnout: all 90.70% · promoters 100.00% · institutions 81.07% · other public 66.56%

For and against are per cent of the votes cast. Turnout is the votes cast as a per cent of the shares each group holds. Institutions are funds, insurers, banks and foreign investors. An ordinary resolution passes with more than half the votes cast, a special one with at least three quarters.

Annual general meeting, 30 Jul 2021, 6 resolutions

Present: 10 promoters and 51 others.The company's voting result (opens in a new tab)

  1. 1 - To receive, consider and adopt the Audited Financial Statements (including Consolidated Audited Financial Statements) of the Company for the year ended on March 31, 2021 and the Reports of the Board of Directors and the Auditors thereon.MoreLess
    Ordinary
    100.00% for0.00% against

    Against: promoters 0.00% · institutions 0.00% · other public 0.00%

    Turnout: all 89.81% · promoters 100.00% · institutions 78.36% · other public 64.44%

  2. 2 - To declare final dividend of Rs. 5/- (50%) per equity share for the Financial Year ended on March 31, 2021.
    Ordinary
    100.00% for0.00% against

    Against: promoters 0.00% · institutions 0.00% · other public 0.00%

    Turnout: all 89.82% · promoters 100.00% · institutions 78.40% · other public 64.44%

  3. 3 - To consider the re-appointment of Mr. Tarun G. Arora (DIN:07185311), as a CEO and Whole Time Director, who retires by rotation and being eligible, offers himself for re-appointment.
    Ordinary
    100.00% for0.00% against

    Against: promoters 0.00% · institutions 0.00% · other public 0.00%

    Turnout: all 89.81% · promoters 100.00% · institutions 78.36% · other public 64.44%

  4. 4 - To re-appoint Mr. Kulin S. Lalbhai (DIN: 05206878) as an Independent Director of the Company for the second term of 5 (five) consecutive years.
    Special
    99.91% for0.09% against

    Against: promoters 0.00% · institutions 0.64% · other public 0.01%

    Turnout: all 89.65% · promoters 100.00% · institutions 77.41% · other public 64.44%

  5. 5 - To ratify remuneration of Cost Auditors.
    Ordinary
    100.00% for0.00% against

    Against: promoters 0.00% · institutions 0.00% · other public 0.00%

    Turnout: all 89.81% · promoters 100.00% · institutions 78.36% · other public 64.44%

  6. 6 - To approve remuneration to Non-Executive Directors.
    Ordinary
    99.87% for0.13% against

    Against: promoters 0.00% · institutions 0.89% · other public 0.00%

    Turnout: all 89.65% · promoters 99.99% · institutions 77.41% · other public 64.44%

For and against are per cent of the votes cast. Turnout is the votes cast as a per cent of the shares each group holds. Institutions are funds, insurers, banks and foreign investors. An ordinary resolution passes with more than half the votes cast, a special one with at least three quarters.

Extraordinary general meeting, 19 Sep 2020, 2 resolutions

Present: 22 promoters and 64 others.The company's voting result (opens in a new tab)

  1. To approve issue and allotment of 21,22,000 Equity Shares to Zydus Family Trust on a preferential allotment basis
    SpecialPromoters have an interest in it
    100.00% for0.00% against

    Against: promoters 0.00% · institutions 0.00% · other public 0.00%

    Turnout: all 82.25% · promoters 93.68% · institutions 48.21% · other public 63.65%

  2. To approve fund raising activities and issuance of securities by the Company
    Special
    100.00% for0.00% against

    Against: promoters 0.00% · institutions 0.00% · other public 0.00%

    Turnout: all 86.54% · promoters 100.00% · institutions 48.21% · other public 63.65%

For and against are per cent of the votes cast. Turnout is the votes cast as a per cent of the shares each group holds. Institutions are funds, insurers, banks and foreign investors. An ordinary resolution passes with more than half the votes cast, a special one with at least three quarters.

Annual general meeting, 27 Aug 2020, 6 resolutions

Present: 11 promoters and 44 others.The company's voting result (opens in a new tab)

  1. To receive, consider and adopt the Audited Financial Statements (including consolidated financial statements) of the Company for the year ended on March 31, 2020 and the Reports of the Board of Directors and Auditors thereon.nMoreLess
    Ordinary
    100.00% for0.00% against

    Against: promoters 0.00% · institutions 0.00% · other public 0.00%

    Turnout: all 86.65% · promoters 100.00% · institutions 48.15% · other public 64.35%

  2. To confirm the Payment of Interim Dividend of Rs. 5/- per equity share of Rs. 10/- each as a final dividend for the Financial Year 2019–2020.n
    Ordinary
    100.00% for0.00% against

    Against: promoters 0.00% · institutions 0.00% · other public 0.00%

    Turnout: all 86.65% · promoters 100.00% · institutions 48.15% · other public 64.35%

  3. To appoint a Director in place of Dr. Sharvil P. Patel (DIN-00131995), who retires by rotation and being eligible, offers himself for re-appointment
    OrdinaryPromoters have an interest in it
    100.00% for0.00% against

    Against: promoters 0.00% · institutions 0.00% · other public 0.00%

    Turnout: all 86.64% · promoters 99.99% · institutions 48.15% · other public 64.35%

  4. To appoint M/s. Mukesh M. Shah & Co., Chartered Accountants [Firm Registration No. 106625W] as Statutory Auditor of the Company to hold office from the conclusion of 26th Annual General Meeting until the conclusion of 31st Annual General Meeting and to fix their remuneration.MoreLess
    Ordinary
    100.00% for0.00% against

    Against: promoters 0.00% · institutions 0.00% · other public 0.01%

    Turnout: all 86.65% · promoters 100.00% · institutions 48.15% · other public 64.35%

  5. To re-appoint Mr. Tarun G. Arora (DIN: 07185311) as a Chief Executive Officer and Whole Time Director.n
    Ordinary
    98.10% for1.90% against

    Against: promoters 0.00% · institutions 29.33% · other public 0.00%

    Turnout: all 86.65% · promoters 100.00% · institutions 48.15% · other public 64.35%

  6. Ratification of remuneration to Cost Auditors.
    Ordinary
    100.00% for0.00% against

    Against: promoters 0.00% · institutions 0.00% · other public 0.00%

    Turnout: all 86.65% · promoters 100.00% · institutions 48.15% · other public 64.35%

For and against are per cent of the votes cast. Turnout is the votes cast as a per cent of the shares each group holds. Institutions are funds, insurers, banks and foreign investors. An ordinary resolution passes with more than half the votes cast, a special one with at least three quarters.

How mutual funds voted

Fund houses must disclose how they vote at every meeting of a company they hold.Funds that hold it

Mutual fund votes, meeting of 4 Aug 2026, 9 fund houses so far (houses' deadline to file 15 Oct 2026)

  • Adoption of Standalone Audited Financial Statements for the financial year ended on March 31, 2026 and the Report of Board of Directors and Auditors thereon
    9 for0 against
  • Adoption of Consolidated Audited Financial Statements for the financial year ended on March 31, 2026 and the Report of Auditors thereon
    9 for0 against
  • Declaration of Dividend of Rs. 1.20 per equity share of Rs. 2/- each for the financial year ended on March 31, 2026
    9 for0 against
  • Re-appointment of Dr. Sharvil P. Patel, as a Non-Executive Director of the Company, liable to retire by rotation
    9 for0 against
  • Appointment of Mr. Apurva S. Diwanji (DIN: 00032072) as an Independent Director of the Company for the term of 5 (five) years
    Against Angel One Mutual Fund, DSP Mutual Fund, Edelweiss Mutual Fund, Jio BlackRock Mutual Fund, Navi Mutual Fund
    • Angel One Mutual FundGovernance concern: Prolonged association with the Promoter Company.
    • DSP Mutual Fund, Jio BlackRock Mutual FundApurva S. Diwanji, 57, is a Senior Partner at Desai & Diwanji, a law firm with over three decades of experience. He served on the board of Zydus Lifesciences Limited, a group company from August 2003 to December 2014 and then again from May 2016 to May 2026 as an Independent Director. Since there has not been a sufficient cooling off period, we will consider his aggregate tenure with the group in computing his board tenure at Zydus Wellness. Given the overall association exceeds ten years, we do not support his appointment. The company must consider appointing him as Non-Executive Non-Independent Director. We do not support the resolution.
    • Edelweiss Mutual Fund, Navi Mutual FundCompliant with law. No concerns w.r.t. profile and time-commitment of the proposed director. Governance concern: Prolonged association with the Promoter Company.
    4 for5 against
  • Ratification of remuneration of R. Nanabhoy & Co., Cost Auditors for the Financial Year ending on March 31, 2027
    9 for0 against

Mutual fund votes, meeting of 30 Jul 2025, 13 fund houses

Each resolution counts the houses whose vote was matched to it; the rest are listed last.

  • Adoption of Standalone Audited Financial Statements for the financial year ended on March 31, 2025 and the Report of Board of Directors and Auditors thereon
    12 for0 against
  • Adoption of Consolidated Audited Financial Statements for the financial year ended on March 31, 2025 and the Report of Auditors thereon
    12 for0 against
  • Declaration of Dividend of Rs. 6/- per equity share of Rs. 10/- each for the financial year ended on March 31, 2025
    12 for0 against
  • Re-appointment of Mr. Ganesh Nayak, as a Non-Executive Director of the Company, liable to retire by rotation
    13 for0 against
  • Re-appointment of Mukesh M. Shah & Co., Chartered Accountants, as Statutory Auditors of the Company for the second term of five consecutive years
    Against HDFC Mutual Fund, Mirae Asset Mutual Fund, Taurus Mutual Fund
    • HDFC Mutual FundMukesh M. Shah & Co., Chartered Accountants were statutory auditors of Zydus Lifesciences Limited (Zydus Lifesciences) – parent company, for over ten years. Considering there hasn’t been a five-year cooling-off period between the Zydus group and Mukesh M. Shah & Co, we do not support their reappointment.
    • Mirae Asset Mutual FundAs per advisory recommendation (Passive holding)
    • Taurus Mutual FundMukesh M. Shah & Co., Chartered Accountants were statutory auditors of Zydus Lifesciences Limited (Zydus Lifesciences) – parent company, for over ten years, their tenure ended in FY17 and were replaced with Deloitte Haskins & Sells LLP. Post expiry of their tenure at Zydus Lifesciences, their association with the Zydus group continues, given they are auditors of Zydus Lifesciences – material subsidiaries - Zydus Animal Health and Investments Limited, since 08 August 2019 and Zydus Wellness since 27 August 2020. Considering there hasn’t been a five-year cooling-off period between the Zydus group and Mukesh M. Shah & Co, we do not support their reappointment.
    10 for3 against
  • Sub-division of equity share of Rs. 10/- each into 5 (five) equity shares of Rs. 2/- each
    12 for0 against
  • Alteration of Capital Clause of the Memorandum of Association of the Company
    12 for0 against
  • Appointment of Hitesh Buch & Associates, Company Secretaries, as Secretarial Auditors of the Company for a term of five consecutive years
    13 for0 against
  • Ratification of remuneration of Dalwadi & Associates, Cost Auditors for the Financial Year ending on March 31, 2026
    12 for0 against
6 proposals not matched to one resolution
  • Item 1, as a fund house numbered it
    1 for0 against
  • Item 2, as a fund house numbered it
    1 for0 against
  • Item 3, as a fund house numbered it
    1 for0 against
  • Item 6, as a fund house numbered it
    1 for0 against
  • Item 7, as a fund house numbered it
    1 for0 against
  • Item 9, as a fund house numbered it
    1 for0 against
6 earlier meetings

Mutual fund votes, meeting of 2 Aug 2024, 10 fund houses

  • Adoption of Standalone Audited Financial Statements for the year ended on March 31, 2024 and the Report of Board of Directors and Auditors thereon
    10 for0 against
  • Adoption of Consolidated Audited Financial Statements for the year ended on March 31, 2024 and the Report of Auditors thereon
    10 for0 against
  • Declaration of Final Dividend of ₹ 5/- per equity share of ₹ 10/- each for the financial year ended on March 31, 2024
    10 for0 against
  • Re-appointment of Mr. Tarun Arora, as a Chief Executive Officer & Whole Time Director of the Company, liable to retire by rotation
    10 for0 against
  • Re-appointment of Mr. Tarun Arora, as a Chief Executive Officer & Whole Time Director of the Company for a period of 5 years
    Against Sundaram Mutual Fund
    • Sundaram Mutual FundTarun Arora’s aggregate remuneration, including pay from wholly owned subsidiary ZWPL, for FY24 was Rs. 70.6 mn. The company has stated that his FY25 remuneration from ZWL will be Rs. 13.6 mn. However, remuneration terms at ZWL have not been disclosed. The company has stated that shareholders may physically inspect the remuneration agreement. We note, regulations require companies to make this disclosure more freely and is followed as a practice by most companies – asking shareholders to physically inspect documents creates an unnecessary hurdle to transparency. The company has also not disclosed remuneration terms from subsidiary ZWPL which comprises 83% of aggregate pay. Given the lack of disclosures, we are unable to ascertain proposed aggregate remuneration and support the resolution.
    9 for1 against
  • Continuation of Mr. Ashish Bhargava as a Nominee Director of the Company
    10 for0 against
  • Approval of Commission payable to the Non-Executive Directors
    10 for0 against
  • Ratification of remuneration of Dalwadi & Associates, Cost Auditors for the Financial Year ending on March 31, 2025
    10 for0 against

Mutual fund votes, meeting of 3 Aug 2023, 10 fund houses

  • Adoption of Standalone Audited Financial Statements for the year ended on March 31, 2023 and the Report of Board of Directors and Auditors thereon.
    10 for0 against
  • Adoption of Consolidated Audited Financial Statements for the year ended on March 31, 2023 and the Report of Auditors thereon.
    10 for0 against
  • Declaration of Final Dividend of ₹ 5/- per equity share of ₹ 10/- each for the financial year ended on March 31, 2023.
    10 for0 against
  • Re-appointment of Dr. Sharvil P. Patel (DIN: 00131995), as a Non-Executive Director of the Company who retires by rotation in the AGM and being eligible, offers himself.
    10 for0 against
  • Re-appointment of Ms. Dharmishtaben N. Raval (DIN: 02792246) as an Independent Director of the Company for the second term of 5 (five) consecutive years.
    Against Motilal Oswal Mutual Fund, Nippon India Mutual Fund, SBI Mutual Fund, Sundaram Mutual Fund
    • Motilal Oswal Mutual FundReappointment is compliant with law. Governance Concern: Proposed term will lead to prolonged association with the Group.
    • Nippon India Mutual FundAssociation may adversely impact independence
    • SBI Mutual Fund, Sundaram Mutual FundMs. Dharmishta Raval, 67, is a practicing lawyer at the Gujarat High Court and at National Company Law Tribunal, Ahmedabad. She attended all four board meetings held in FY23. She has been on the board of Zydus Wellness Limited since 11 March 2019 and on the board of Zydus Lifesciences Limited (parent entity) since 16 May 2014. We believe that the length of tenure is inversely proportionate to the independence of a director. Her overall tenure with the group will exceed ten years in May 2024 (within six months from the proposed reappointment) and thus, we do not support her reappointment as Independent Director given the extended association.
    6 for4 against
  • Re-appointment of Mr. Srivishnu R. Nandyala (DIN: 00025063) as an Independent Director of the Company for the second term of 5 (five) consecutive years.
    10 for0 against
  • Appointment of Mr. Akhil A. Monappa (DIN: 09784366) as an Independent Director of the Company for the first term of 5 (five) consecutive years.
    10 for0 against
  • Ratification of remuneration of Dalwadi & Associates, Cost Auditors for the Financial Year ending on March 31, 2024
    10 for0 against

Mutual fund votes, meeting of 29 Jul 2022, 9 fund houses

  • Adoption of Standalone Audited Financial Statements for the year ended on March 31, 2022 and the Report of Board of Directors and Auditors thereon
    9 for0 against
  • Adoption of Consolidated Audited Financial Statements for the year ended on March 31, 2022 and the Report of Auditors thereon
    9 for0 against
  • Declaration of Final Dividend of Rs. 5/- per equity share of Rs. 10/- each for the financial year ended on March 31, 2022
    9 for0 against
  • Re-appointment of Mr. Ganesh N. Nayak (DIN: 00017481), as a Non-Executive Director of the Company who retires by rotation in the AGM and being eligible, offers himself for re-appointment.
    9 for0 against
  • Ratification of remuneration to Cost Auditors
    9 for0 against

Mutual fund votes, meeting of 30 Jul 2021, 9 fund houses

  • 1 - To receive, consider and adopt the Audited Financial Statements (including Consolidated Audited Financial Statements) of the Company for the year ended on March 31, 2021 and the Reports of the Board of Directors and the Auditors thereon.MoreLess
    9 for0 against
  • 2 - To declare final dividend of Rs. 5/- (50%) per equity share for the Financial Year ended on March 31, 2021.
    9 for0 against
  • 3 - To consider the re-appointment of Mr. Tarun G. Arora (DIN:07185311), as a CEO and Whole Time Director, who retires by rotation and being eligible, offers himself for re-appointment.
    9 for0 against
  • 4 - To re-appoint Mr. Kulin S. Lalbhai (DIN: 05206878) as an Independent Director of the Company for the second term of 5 (five) consecutive years.
    8 for0 against

    1 abstained

  • 5 - To ratify remuneration of Cost Auditors.
    9 for0 against
  • 6 - To approve remuneration to Non-Executive Directors.
    8 for0 against

    1 abstained

Mutual fund votes, meeting of 19 Sep 2020, 8 fund houses

Each resolution counts the houses whose vote was matched to it; the rest are listed last.

  • To approve issue and allotment of 21,22,000 Equity Shares to Zydus Family Trust on a preferential allotment basis
    6 for0 against

    2 abstained

  • To approve fund raising activities and issuance of securities by the Company
    4 for0 against

    1 abstained

2 proposals not matched to one resolution
  • Issue of equity shares, preference shares or other equity-linked securities aggregating up to Rs 7.5 bn by way of public issue or preferential issue including QIP
    2 for0 against
  • To authorise the Board of Directors to create, issue, offer and allot (including with provisions for reservations on firm and/or competitive basis, or such part of issue and for such categories of persons as may be permitted) such number of Securities (as defined hereinafter), for cash, in one or more tranches, with or without green shoe option, whether Rupee denominated or denominated in foreign currency, for an aggregate amount up to Rs. 750,00,00,000/-, by way of one or more public and/or private offerings and/or on a preferential allotment basis and/or a qualified institutions placementMoreLess
    0 for0 against

    1 abstained

Mutual fund votes, meeting of 27 Aug 2020, 8 fund houses

  • To receive, consider and adopt the Audited Financial Statements (including consolidated financial statements) of the Company for the year ended on March 31, 2020 and the Reports of the Board of Directors and Auditors thereon.nMoreLess
    6 for0 against

    2 abstained

  • To confirm the Payment of Interim Dividend of Rs. 5/- per equity share of Rs. 10/- each as a final dividend for the Financial Year 2019–2020.n
    6 for0 against

    2 abstained

  • To appoint a Director in place of Dr. Sharvil P. Patel (DIN-00131995), who retires by rotation and being eligible, offers himself for re-appointment
    6 for0 against

    2 abstained

  • To appoint M/s. Mukesh M. Shah & Co., Chartered Accountants [Firm Registration No. 106625W] as Statutory Auditor of the Company to hold office from the conclusion of 26th Annual General Meeting until the conclusion of 31st Annual General Meeting and to fix their remuneration.MoreLess
    6 for0 against

    2 abstained

  • To re-appoint Mr. Tarun G. Arora (DIN: 07185311) as a Chief Executive Officer and Whole Time Director.n
    6 for0 against

    2 abstained

  • Ratification of remuneration to Cost Auditors.
    6 for0 against

    2 abstained

Each fund house counted once, from its own disclosure; the reasons are its own words.

Fines and tax disputes

Reported in the filing for the quarter to Sep 2026.

  • Fine or penaltyItaly — Agenzia delle Entrate (Revenue Agency)Since 23 Sep 2026

    Imposed penalty on Comfort Click Limited, United Kingdom, a wholly owned step down subsidiary of Euro 665.67 (approximately ₹ 72,710 as per exchange rate published on Bloomberg dated September 23, 2026) and interest.

    Alleged late payment of VAT for the period October, 2023 and December, 2023
  • Fine or penaltySuperintendent, Governorpet, Vijaywada II, Andhra PradeshSince 13 Jul 2026

    The Order is passed against Zydus Wellness Products Limited ("ZWPL"), a wholly owned subsidiary company under section 74 of the CGST Act, 2017 / Andhra Pradesh GST Act, 2017 read with section 20 of the IGST Act, 2017 confirming tax demand along with penalty of Rs. 0.46 Lakhs and applicable interest for the FY 2020-21.

    Alleged short payment of tax under Reverse Charge Mechanism for the FY 2020-21
  • Fine or penaltySuperintendent, Governorpet, Vijaywada II, Andhra PradeshSince 13 Jul 2026

    The Order is passed against Zydus Wellness Products Limited ("ZWPL"), a wholly owned subsidiary company under section 74 of the CGST Act, 2017 / Andhra Pradesh GST Act, 2017 read with section 20 of the IGST Act, 2017 confirming tax demand along with penalty of Rs. 0.37 Lakhs and applicable interest for the FY 2022-23.

    Alleged short payment of tax under Reverse Charge Mechanism for the FY 2022-23
  • Fine or penaltySuperintendent, Governorpet, Vijaywada II, Andhra PradeshSince 13 Jul 2026

    The Order is passed against Zydus Wellness Products Limited ("ZWPL"), a wholly owned subsidiary company under section 74 of the CGST Act, 2017 / Andhra Pradesh GST Act, 2017 read with section 20 of the IGST Act, 2017 confirming tax demand along with penalty of Rs. 0.36 Lakhs and applicable interest for the FY 2023-24.

    Alleged short payment of tax under Reverse Charge Mechanism for the FY 2023-24
  • Fine or penaltyDeputy Commissioner, Appellate Authority, Jabalpur, Madhya PradeshSince 21 Sep 2026

    The appeal order is passed against Zydus Wellness Products Limited (“ZWPL”) [successor of Zydus Wellness Sikkim (“ZWS”), a partnership Firm], a wholly owned subsidiary company under Madhya Pradesh Entry Tax Act and VAT Act, confirming tax demand along with penalty of Rs 0.01 Lakhs and applicable Interest for FY 2015-16.

    Alleged short payment of Madhya Pradesh Entry Tax for FY 2015-16.
  • Fine or penaltyDeputy Commissioner, Appellate Authority, Jabalpur, Madhya PradeshSince 21 Sep 2026

    The appeal order is passed against Zydus Wellness Products Limited (“ZWPL”) [successor of Zydus Wellness Sikkim (“ZWS”), a partnership Firm], a wholly owned subsidiary company under Madhya Pradesh VAT Act, confirming tax demand along with penalty of Rs 0.10 Lakhs and applicable Interest for FY 2016-17.

    Alleged short payment of Madhya Pradesh VAT for FY 2016-17.
  • Fine or penaltyDeputy Commissioner, Appellate Authority, Jabalpur, Madhya PradeshSince 21 Sep 2026

    The appeal order is passed against Zydus Wellness Products Limited (“ZWPL”) [successor of Zydus Wellness Sikkim (“ZWS”), a partnership Firm], a wholly owned subsidiary company under Madhya Pradesh VAT Act, confirming tax demand along with penalty of Rs 0.10 Lakhs and applicable Interest for FY 2015-16.

    Alleged short payment of Madhya Pradesh VAT for FY 2015-16.
  • Tax disputeThe Directorate General of Goods and Services Tax Intelligence, Surat Zonal UnitSince 26 Feb 2025
    The Revenue filed its affidavit-in-reply to the writ petition. At the hearing held on August 17, 2026, ZWPL sought time to file a rejoinder affidavit to the Revenue's reply, which was thereafter filed before Hon'ble Court. Thereafter, the matter was subsequently listed on September 3, 2026, however the Revenue Counsel sought an adjournment to examine the rejoinder filed by ZWPL. The matter was again listed on September 24, 2026, but could not be taken up for hearing due to paucity of time. The interim protection granted by the Hon'ble Court continues to operate. The next hearing is likely to be scheduled in the month of October, 2026. The period covered by the OIO relates to pre-acquisition period prior to January 30, 2019, and hence liability stands fully indemnified by Heinz Italia S.P.A.MoreLess
    At the filing before: Zydus Wellness Products Limited, a wholly owned subsidiary ("ZWPL") had filed a writ petition before the Hon’ble Gujarat High Court (“Court”) under Article 226 of the Constitution of India, challenging the OIO dated September 30, 2025. The matter was listed for hearing on January 9, 2026 and the Court has granted ad-interim relief to ZWPL, restraining further proceedings in relation to the said OIO. Accordingly, a letter was submitted to the concerned Department on January 12, 2026, intimating the grant of interim relief and requesting that no recovery proceedings be initiated. Pursuant to the writ petition filed before the Hon’ble Gujarat High Court challenging the Order-in-Original dated September 30, 2025, the matter was listed for hearing on April 16, 2026; however, the hearing could not be conducted due to paucity of time. Thereafter, the matter was listed again, but was not taken up for hearing for the same reason. The interim protection granted by the Hon’ble Court continues to operate. The next hearing is likely to be scheduled in the month of August, 2026. The period covered by the OIO relates to pre-acquisition period prior to January 30, 2019, and hence liability stands fully indemnified by Heinz Italia S.P.A.MoreLess

In the company's own words, from its latest governance filing.

Investor complaints and compliance

Quarter by quarter.

Investor complaints received and resolved, the company's own count

  • Received
  • Resolved

Open at the quarter's end

At most 1 complaint open, quarter to Jun 2025.
The board is made up as the listing rules require
Yes
The board has a regular chairperson
Yes
The company has a risk management committee
Yes
The chair is related to the managing director
No
The filing has a part on fines and penalties
Yes
The filing has a part on tax disputes
Yes
There was a cyber security incident in the quarter
No

The company's own answers in its filing.